STRS Ohio’s Aurinia Pharmaceuticals AUPH Stock Holding History

STRS Ohio’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$977K	Buy	57,600 +1,100	+2%	+$17.6K	﹤0.01%	749
2026 Q1	$837K	Buy	56,500 +2,500	+5%	+$36.5K	﹤0.01%	769
2025 Q4	$861K	Sell	54,000 -7,000	-11%	-$99.2K	﹤0.01%	754
2025 Q3	$674K	Sell	61,000 -18,100	-23%	-$198K	﹤0.01%	859
2025 Q2	$670K	Hold	79,100	–	–	﹤0.01%	1078
2025 Q1	$636K	Buy	79,100 +4,800	+6%	+$38.9K	﹤0.01%	1040
2024 Q4	$667K	Buy	74,300 +10,300	+16%	+$84K	﹤0.01%	1012
2024 Q3	$469K	Hold	64,000	–	–	﹤0.01%	1291
2024 Q2	$365K	Buy	64,000 +6,500	+11%	+$34.2K	﹤0.01%	1375
2024 Q1	$288K	Sell	57,500 -3,600	-6%	-$24.4K	﹤0.01%	1448
2023 Q4	$549K	Sell	61,100 -12,300	-17%	-$101K	﹤0.01%	1234
2023 Q3	$570K	Hold	73,400	–	–	﹤0.01%	1173
2023 Q2	$710K	Buy	73,400 +46,800	+176%	+$486K	﹤0.01%	1075
2023 Q1	$291K	Buy	26,600 +25,300	+1,946%	+$223K	﹤0.01%	1514
2022 Q4	$5K	Hold	1,300	–	–	﹤0.01%	1951
2022 Q3	$9K	Hold	1,300	–	–	﹤0.01%	1969
2022 Q2	$13K	Buy	+1,300	New	+$14.5K	﹤0.01%	1981

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's AUPH Position: Q2 2026 in Review

STRS Ohio increased its Aurinia Pharmaceuticals (AUPH) stake by 1.9% in Q2 2026, buying an estimated $17.6K and bringing the position to 57,600 shares worth $977K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

STRS Ohio first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

STRS Ohio held 57,600 shares of Aurinia Pharmaceuticals worth $977K as of Q2 2026.
STRS Ohio bought 1,100 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $17.6K.
Aurinia Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #749 holding.
STRS Ohio first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.